CR10324A - Moleculas no peptidicas para detectar y tratar tumores - Google Patents

Moleculas no peptidicas para detectar y tratar tumores

Info

Publication number
CR10324A
CR10324A CR10324A CR10324A CR10324A CR 10324 A CR10324 A CR 10324A CR 10324 A CR10324 A CR 10324A CR 10324 A CR10324 A CR 10324A CR 10324 A CR10324 A CR 10324A
Authority
CR
Costa Rica
Prior art keywords
detect
treat tumors
peptidic molecules
acidity
tumors
Prior art date
Application number
CR10324A
Other languages
English (en)
Inventor
E Summerton James
Original Assignee
E Summerton James
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/395,487 external-priority patent/US20070231256A1/en
Priority claimed from US11/449,495 external-priority patent/US8084610B2/en
Priority claimed from US11/449,508 external-priority patent/US20080124274A1/en
Application filed by E Summerton James filed Critical E Summerton James
Publication of CR10324A publication Critical patent/CR10324A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una de las caracteristicas mas universales de los tumores malignos es su acidez. Las oncotools son pequenas moleculas sinteticas no peptidicas disenadas para aprovechar esta acidez para la deteccion temprana y la destruccion de tumores. Cada oncotool tiene una estructura que es anionica e hidrofila a pH 7,4 y de este modo repele las superficies cargadas negativamente de las celulas en los tejidos normales.
CR10324A 2006-03-30 2008-09-29 Moleculas no peptidicas para detectar y tratar tumores CR10324A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/395,487 US20070231256A1 (en) 2006-03-30 2006-03-30 Compositions and methods for detecting and treating tumors containing acidic areas
US11/449,495 US8084610B2 (en) 2006-06-07 2006-06-07 Compositions and methods for detecting and treating tumors containing acidic areas
US11/449,508 US20080124274A1 (en) 2006-06-07 2006-06-07 Compositions and methods for detecting and treating tumors containing acidic areas

Publications (1)

Publication Number Publication Date
CR10324A true CR10324A (es) 2008-11-26

Family

ID=39870100

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10324A CR10324A (es) 2006-03-30 2008-09-29 Moleculas no peptidicas para detectar y tratar tumores

Country Status (1)

Country Link
CR (1) CR10324A (es)

Similar Documents

Publication Publication Date Title
CY1120257T1 (el) ΠΥΡΡΟΛΟ[2,3b]ΠΥΡΙΔΙΝ-4-ΥΛΑΜΙΝΕΣ ΚΑΙ ΠΥΡΡΟΛΟ[2,3b]ΠΥΡΙΜΙΔΙΝ-4-ΥΛΑΜΙΝΕΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΚΙΝΑΣΩΝ JANUS
BRPI0814529A2 (pt) Derivados de 2-3-dihidrobenzo[1,4]dioxin-2-ilmetil como antagonistas alfa2c para o uso no tratamento de doenças do sistema nervoso periférico e central.
ATE512024T1 (de) STOßDÄMPFUNGSVORRICHTUNG UND MIT DIESER VORRICHTUNG AUSGESTATTETER SITZ
GT200600407A (es) Compuestos ppar activos
BR112016001851A2 (pt) material ondulado tridimensional com aberturas tratado
UY28933A1 (es) Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos
BRPI0607002A2 (pt) aptámeros terapêuticos úteis no tratamento de desordens relacionadas a complemento
CL2007001665A1 (es) Anticuerpo o fragmento del mismo con actividad neutralizante de la proteina nr 10; agente que lo comprende; y su uso para prevenir o tratar una enfermedad inflamatoria.
CY1114153T1 (el) Παραγωγα κυκλοαλκανοπυρρολοκαρβαzολιου και η χρηση αυτων ως αναστολεις parp, vegfr2 και mlk3
BR112014023005A2 (pt) diagnóstico rápido e tratamentos personalizados para acne
CR9365A (es) Compuestos y metodos para la inhibicion de la protein-cinasa raf
BRPI0607507A2 (pt) método in vitro para a identificação de compostos para tratamento do cáncer
BR0014924B1 (pt) processo e sistema para iluminar a retina de um olho, e processo e sistema para determinar uma aberraÇço de frente de onda de um elemento àptico.
BRPI0715718A2 (pt) Anticorpo, métodos de triar para um anticorpo para o domínio extracelular de uma proteína prlr, de alterar sistematicamente anticorpos e triar para um anticorpo para o domínio extracelular de uma proteína prlr, de tratar um indivíduo que sofre de câncer, de alvejar uma célula tumoral que expressa prlr, de usar uma célula hospedeira, de identificar um indivíduo com necessidade de tratamento com um anticorpo anti-prlr, e de monitorar terapia de câncer em um indivíduo, molécula de ácido nucleico isolada, vetor de expressão, célula hospedeira, composição farmacêutica, e, kit
AR084723A1 (es) microARN (miARN) COMO BIOMARCADOR PARA LA IDENTIFICACION DEL CANCER COLORRECTAL FAMILIAR Y NO FAMILIAR
BRPI0606112A2 (pt) 3 - heteroaril - 3 - hidróxi - 2 - amino - propil aminas e compostos relacionados, bem como uso dos mesmos e composição farmacêutica
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
DE602005000485D1 (de) Nukleinsäurenachweisverfahren mittels mehreren Paaren von Donorflurophoren und Quenchemolekülen in derselben Sonde
NO20075527L (no) Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
BRPI0511802A (pt) processo para criação de meios para uso em separadores de ar/óleo
BRPI0612424A2 (pt) composiÇÕes e mÉtodos para tratar condiÇÕes relacionadas com a sinalizaÇço da efrina com cupredoxinas
CL2012002887A1 (es) Combinación farmacéutica que comprende compuestos derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituida, compuestos derivados de n-(2-arilamino)arilsulfonamida y opcionalmente otros agentes farmacéuticos adicionales; kit faramacéutico; método de tratamiento; y su uso para el tratamiento o la profilaxis del cáncer.
BRPI0718469A2 (pt) Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto.
CL2009001076A1 (es) Nanoparticulas que comprende una sustancia formadora de particulas y una proteina; composicion que comprende dichas nanoparticulas; procedimiento para suministrar una proteina a traves de la membrana hematoencefalica; uso de la composicion para profilaxis o tratar enfermedades del sistema nervioso central.
AR048135A1 (es) Uso de gen de amiloide a serico en el diagnostico y tratamiento del glaucoma y en la identificacion de agentes anti-glaucoma.